Cutenox 40 mg Injection

Product Information

References

1. DailyMed (FDA) — Enoxaparin Sodium Injection Prescribing Information
2. ScienceDirect — Enoxaparin — Pharmacology Overview

Medically reviewed. Last updated: [21/06/2026]. This content is for informational purposes and does not replace consultation with a licensed physician.

How it works

Enoxaparin is a low molecular weight heparin that inhibits Factor Xa and, to a lesser extent, thrombin, interrupting the coagulation cascade before clots can form or grow. Compared to unfractionated heparin, its more predictable dose-response means it generally doesn't require routine blood monitoring for most indications, which is part of why it's widely used for at-home, self-administered prophylaxis.

Cutenox 40mg is a low molecular weight heparin (LMWH) injection containing enoxaparin sodium, used primarily to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in surgical and immobile patients, and also used off-label in IVF and recurrent pregnancy loss to support uterine blood flow and implantation. It is manufactured by Gland Pharma and administered as a subcutaneous injection, typically self-administered after training.

What Cutenox 40mg Is Used For

• DVT prevention: standard prophylaxis for surgical patients (especially orthopedic and abdominal surgery) and immobile hospitalized patients at risk of clot formation
• Pulmonary embolism: used in both prevention and as part of treatment for confirmed PE, often alongside other anticoagulation management
• Unstable angina / acute MI: used in some cardiovascular protocols to reduce clot-related complications
• IVF and recurrent pregnancy loss (off-label): used in women with clotting disorders such as antiphospholipid syndrome to support uterine blood flow and reduce miscarriage risk linked to micro-clotting

Dosing depends on indication and body weight, and must be set by a prescribing physician — typical DVT prophylaxis dosing is 40mg once daily, given subcutaneously.

• Inject subcutaneously into the abdomen (alternating sides) or thigh, never intramuscularly
• Do not expel the air bubble from prefilled syringes before injecting — it's part of the dosing mechanism
• Rotate injection sites to reduce bruising and irritation
• Do not rub the injection site after administering
• Patients with reduced kidney function require dose adjustment — inform your doctor of any kidney issues before starting

The most common side effects are mild bruising or pain at the injection site; the main serious risk to watch for is abnormal bleeding.

• Injection site bruising or pain: common and usually mild
• Minor bleeding risk: increased tendency to bruise or bleed slightly more easily
• Nausea, dizziness: reported less frequently

Seek medical attention immediately for: unusual or heavy bleeding (nosebleeds, blood in urine/stool, heavy menstrual bleeding), signs of allergic reaction (rash, swelling, breathing difficulty), or sudden back pain/numbness if enoxaparin was used around spinal procedures (risk of spinal hematoma).

• Active bleeding disorders: not recommended for patients with active or uncontrolled bleeding
• Kidney function: dose adjustment required for renal impairment, as enoxaparin is cleared renally
• Pregnancy: commonly used in pregnancy for women with diagnosed clotting disorders or recurrent pregnancy loss, under physician supervision
• Drug interactions: avoid combining with NSAIDs, aspirin, or other anticoagulants unless specifically directed by your doctor, due to increased bleeding risk
• Spinal/epidural procedures: timing around spinal anesthesia must be carefully managed by your care team due to spinal hematoma risk